OQS
MRK icon

Occudo Quantitative Strategies’s Merck MRK Stock Holding History

Occudo Quantitative Strategies’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,567
Closed -$389K – 894
2026
Q1 		$389K Buy
+3,567
New +$412K 0.02% 538
2025
Q4 		– Sell
-18,766
Closed -$1.58M – 838
2025
Q3 		$1.58M Buy
+18,766
New +$1.55M 0.19% 139
2025
Q2 		– Sell
-8,138
Closed -$726K – 804
2025
Q1 		$726K Buy
+8,138
New +$760K 0.1% 293
2024
Q4 		– Sell
-47,618
Closed -$5.41M – 842
2024
Q3 		$5.41M Buy
+47,618
New +$5.66M 0.99% 12
2022
Q3 		– Sell
-44,237
Closed -$4.03M – 1343
2022
Q2 		$4.03M Sell
44,237
-32,524
-42% -$2.88M 0.33% 57
2022
Q1 		$6.3M Buy
+76,761
New +$6.05M 0.53% 6
2021
Q4 		– Sell
-32,033
Closed -$2.41M – 1180
2021
Q3 		$2.41M Buy
+32,033
New +$2.44M 0.29% 56

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Occudo Quantitative Strategies's MRK Position: Q2 2026 in Review

Occudo Quantitative Strategies sold out of Merck (MRK) in Q2 2026, closing a stake of 3,567 shares — an estimated $389K sold.

Occudo Quantitative Strategies first reported a position in MRK in Q3 2021 and held it in 7 quarters. The position peaked at $6.3M in Q1 2022. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Occudo Quantitative Strategies reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 3,567 Merck shares in Q2 2026, an estimated $389K.
  • Occudo Quantitative Strategies first reported a position in Merck in Q3 2021 and held it in 7 quarters.
  • Occudo Quantitative Strategies's Merck position peaked at $6.3M in Q1 2022.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2026, filed 13 Aug 2026.